Atlas Trials

A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise

Clinical trial NCT01809327 · COMPLETED

Trial details

NCT number
NCT01809327
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2013-06-04
Primary completion
2014-12-02
Enrollment
1186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.